help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0190
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/9/4204    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaoka, T.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaoka, T.
Right arrow Articles by Kobayashi, M.
Endocrinology Vol. 144, No. 9 4204-4214
Copyright © 2003 by The Endocrine Society

Dual Role of Src Homology Domain 2-Containing Inositol Phosphatase 2 in the Regulation of Platelet-Derived Growth Factor and Insulin-Like Growth Factor I Signaling in Rat Vascular Smooth Muscle Cells

Toshiyasu Sasaoka, Kosei Kikuchi, Tsutomu Wada, Akira Sato, Hiroyuki Hori, Shihou Murakami, Kazuhito Fukui, Hajime Ishihara, Rina Aota, Ikuko Kimura and Masashi Kobayashi

Department of Clinical Pharmacology (T.S., K.K., R.A., I.K.) and First Department of Internal Medicine (T.W., A.S., H.H., S.M., K.F.), Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan; and Sainou Hospital (H.I.), Toyama 930-0887, Japan

Address all correspondence and requests for reprints to: Toshiyasu Sasaoka, M.D., Ph.D., Department of Clinical Pharmacology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. E-mail: tsasaoka-tym{at}umin.ac.jp.

Src homology domain 2 (SH2)-containing inositol phosphatase 2 (SHIP2) possesses 5-phosphatase activity and an SH2 domain. The role of SHIP2 in platelet-derived growth factor (PDGF) and IGF-I signaling was studied by expressing wild-type (WT-) and a catalytically defective ({Delta}IP-) SHIP2 into rat aortic smooth muscle cells by adenovirus-mediated gene transfer. PDGF- and IGF-I-induced tyrosine phosphorylation of their respective receptors and phosphatidylinositol 3-kinase (PI3-kinase) activity were not affected by the expression of either WT- or {Delta}IP-SHIP2. SHIP2 possessed 5'-phosphatase activity to hydrolyze the PI3-kinase product phosphatidylinositol 3,4,5-trisphosphate in vivo. Akt and glycogen synthase kinase 3ß are known to be downstream molecules of PI3-kinase, leading to the antiapoptotic effect. Overexpression of WT-SHIP2 inhibited PDGF- and IGF-I-induced phosphorylation of these molecules and the protective effect of poly(ADP-ribose) polymerase degradation, whereas these phosphorylations and the protective effect were enhanced by the expression of {Delta}IP-SHIP2, which functions in a dominant negative fashion. Regarding the Ras-MAPK pathway, PDGF- and IGF-I-induced tyrosine phosphorylation of Shc was not affected by the expression of either WT- or {Delta}IP-SHIP2, whereas both expressed SHIP2 associated with Shc. Importantly, PDGF and IGF-I stimulation of Shc/Grb2 binding, MAPK activation, and 5-bromo-2'-deoxyuridine incorporation were all decreased in both WT- and {Delta}IP-SHIP2 expression. These results indicate that SHIP2 plays a negative regulatory role in PDGF and IGF-I signaling in vascular smooth muscle cells. As the bifunctional role, our results suggest that SHIP2 regulates PDGF- and IGF-I-mediated signaling downstream of PI3-kinase, leading to the antiapoptotic effect via 5-phosphatase activity, and that SHIP2 regulates the growth factor-induced Ras-MAPK pathway mainly via the SH2 domain.




This article has been cited by other articles:


Home page
EndocrinologyHome page
T. Wada, M. Naito, H. Kenmochi, H. Tsuneki, and T. Sasaoka
Chronic Nicotine Exposure Enhances Insulin-Induced Mitogenic Signaling via Up-Regulation of {alpha}7 Nicotinic Receptors in Isolated Rat Aortic Smooth Muscle Cells
Endocrinology, February 1, 2007; 148(2): 790 - 799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. K. Prasad and S. J. Decker
SH2-containing 5'-Inositol Phosphatase, SHIP2, Regulates Cytoskeleton Organization and Ligand-dependent Down-regulation of the Epidermal Growth Factor Receptor
J. Biol. Chem., April 1, 2005; 280(13): 13129 - 13136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, T. Sasaoka, T. Fujimori, T. Oya, Y. Ishii, H. Sabit, M. Kawaguchi, Y. Kurotaki, M. Naito, T. Wada, et al.
Deletion of the PDGFR-{beta} Gene Affects Key Fibroblast Functions Important for Wound Healing
J. Biol. Chem., March 11, 2005; 280(10): 9375 - 9389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society